Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer

F. Parisi, M.G. Razeti, E. Blondeaux, L. Arecco, M. Perachino, M. Tagliamento, A. Levaggi, P. Fregatti, F. Poggio, M. Lambertini

Research output: Contribution to journalArticlepeer-review

Abstract

Breast cancer is the most frequent malignancy diagnosed in premenopausal women. In this age group, breast tumors tend to be diagnosed at more advanced stages and to harbor more aggressive biological features. In addition, specific age-related issues including genetic counseling, fertility preservation, impact on social and couple relationships, working life, and management of long-term side effects should be considered highly relevant when managing early breast cancer in premenopausal women. Therefore, the care of these patients is particularly complex and a multidisciplinary approach is mandatory. The present review summarizes the current state of art in the adjuvant systemic treatment of premenopausal women with early breast cancer focusing on the optimal chemotherapy, endocrine therapy, and targeted therapy approaches in this specific patient population. © The Author(s) 2020.
Original languageEnglish
JournalClin. Med. Insights: Oncol.
Volume14
DOIs
Publication statusPublished - 2020

Keywords

  • ONCOLOGIA
  • REVIEW
  • RIS

Fingerprint

Dive into the research topics of 'Current State of the Art in the Adjuvant Systemic Treatment of Premenopausal Patients With Early Breast Cancer'. Together they form a unique fingerprint.

Cite this